NCT03054740

Vapocoolant Spray Used Prior to Intravenous (IV) Insertions

Will Patients Perceive a Vapocoolant Spray to be Effective in Reducing Pain and Increasing Satisfaction With Insertion at an Intravenous Site?

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Aultman Health Foundation · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.

Detailed description

This is a single blind interventional study with a post design using a convenience sample of patients undergoing a Nuclear Medicine Stress Test. The patient selection and intervention will be randomized in order to ensure a high validity study. The interventional treatment used will be a ethyl chloride mist spray manufactured by the Gebauer Company. The placebo spray that will be used is manufactured by BioLogic Aqua Research Technologies International Inc. The spray is called Nature's Tears Mist and is a sterile water. The patient's for this study are required to have intravenous cannulation (IV) access. This is a painful and invasive procedure in which a vapocoolant may confer benefit for the relief of pain.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	Gebauer Ethyl Chloride	Will be administered according to manufacturers recommendations which is to spray the aerosol can for 4-10 seconds from a distance of 3 to 9 inches. Do not spray longer than 10 seconds.
DRUG	Nature's Tears	Sterile water mist will be administered 1-2 sprays prior to intravenous access

Timeline

• Start date: 2017-02-27
• Primary completion: 2017-04-28
• Completion: 2017-04-28
• First posted: 2017-02-16
• Last updated: 2018-10-03
• Results posted: 2018-10-03

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study